In the retatrutide trials, a dose range of 1 to 12 mg per week subcutaneously was studied
Chen C, Zhang D, Wu D, Chen F, Li Z, Hu Y
What many people don't realize is just how strongly sleep apnea and body weight are connected: Approximately 40% of people with obesity have significant sleep apnea Around 70% of sleep apnea patients are classified as obese A mere 10% increase in body weight can increase your sleep apnea risk sixfold Conversely, losing just 10% of your body weight can dramatically decrease sleep apnea severity This strong relationship explains why weight loss has always been recommended for sleep apnea management
Trllinger, Svenja Godbersen, Shahana Sengupta, Adrian Kaufmann, Sren Krogsgaard Thomsen, Bolette Hartmann, Yi-Chun Chen, Anna E
Patients receive guidance on: Choosing the right form of semaglutide Proper dosing and timing instructions How to take semaglutide correctly Managing side effects Supporting long-term weight loss and metabolic health This personalized approach helps ensure safe treatment and optimal outcomes
